Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Zytiga. Show all posts
Showing posts with label Zytiga. Show all posts
Monday, July 15, 2013

Abiraterone: Hint of considerable added benefit for patients with metastatic prostate cancer

›
In continuation of  my update on Abiraterone Abiraterone acetate (abiraterone for short, trade name: Zytiga) has been approved in Ger...
Tuesday, July 24, 2012

For advanced prostate cancer, new drug slows disease

›
In continuation of my update on  abiraterone The study is the first randomized clinical trial to document expanded benefits among a pa...
1 comment:
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.